News Daily News P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis Todd Neale November 21, 2022
News Conference News AHA 2022 China Rural Intervention Still Reaping BP Control Wins at 3 Years L.A. McKeown November 09, 2022
News Conference News AHA 2022 PRECISE CT-Based Strategy Allows Clinicians to ‘Do Less’ for Stable Chest Pain Yael L. Maxwell November 06, 2022
Presentation TCT 2022 TCT 284: Long-Term Cost-Effectiveness of Fractional Flow Reserve in Stable and Unstable Angina Patients Presenter: David Hong September 17, 2022
News Conference News ESC 2022 P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER Todd Neale August 29, 2022
News Daily News Wearable Devices Are Cost-effective AF Screening Tools Caitlin E. Cox August 10, 2022
Presentation TVT 2022 Quality-of-life Assessments and Cost-effectiveness Analyses in TTVI Trials Presenter: Geraldine Ong, Gilbert H. L. Tang, Yan Topilsky June 10, 2022
News Conference News ESC Heart Failure 2022 Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF Shelley Wood May 26, 2022
News Conference News ACC 2022 Large Smartwatch Study Confirms AF in Most Patients Who Seek Care: mAF-App II Yael L. Maxwell April 07, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Daily News Deep-Learning Tool Can Gauge Plaque Burden, Stenosis Severity on CCTA Yael L. Maxwell March 28, 2022
News Daily News Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT Yael L. Maxwell February 17, 2022
News Daily News In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report Michael O'Riordan January 27, 2022